284 related articles for article (PubMed ID: 21855854)
1. Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab.
Lick SD; Beckles DL; Piovesana G; Vaidya S; Indrikovs A; Barbagelata NA; Valentine V
Ann Thorac Surg; 2011 Oct; 92(4):1428-34. PubMed ID: 21855854
[TBL] [Abstract][Full Text] [Related]
2. Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: a strategy to shorten left ventricular assist device support.
Lick SD; Vaidya S; Kollar AC; Boor PJ; Vertrees RA
J Heart Lung Transplant; 2008 Sep; 27(9):1036-9. PubMed ID: 18765198
[TBL] [Abstract][Full Text] [Related]
3. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
4. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
[TBL] [Abstract][Full Text] [Related]
5. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation.
Pascual J; Pirsch JD; Odorico JS; Torrealba JR; Djamali A; Becker YT; Voss B; Leverson GE; Knechtle SJ; Sollinger HW; Samaniego-Picota MD
Transplantation; 2009 Jan; 87(1):125-32. PubMed ID: 19136902
[TBL] [Abstract][Full Text] [Related]
7. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
Yuan XP; Wang CX; Gao W; Fu Q; He XS
Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
[TBL] [Abstract][Full Text] [Related]
8. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
Sampaio MS; Kadiyala A; Gill J; Bunnapradist S
Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462
[TBL] [Abstract][Full Text] [Related]
9. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival.
Gonzalez-Stawinski GV; Cook DJ; Chang AS; Banbury MK; Navia JL; Hoercher K; Lober C; Atik FA; Taylor DO; Yamani MH; Young JB; Starling RC; Smedira NG
J Heart Lung Transplant; 2006 Jun; 25(6):613-8. PubMed ID: 16730565
[TBL] [Abstract][Full Text] [Related]
10. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes.
Joyce DL; Southard RE; Torre-Amione G; Noon GP; Land GA; Loebe M
J Heart Lung Transplant; 2005 Dec; 24(12):2054-9. PubMed ID: 16364849
[TBL] [Abstract][Full Text] [Related]
11. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
12. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
[TBL] [Abstract][Full Text] [Related]
14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
15. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation.
Loh E; Bergin JD; Couper GS; Mudge GH
J Heart Lung Transplant; 1994; 13(2):194-201. PubMed ID: 8031799
[TBL] [Abstract][Full Text] [Related]
16. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
[TBL] [Abstract][Full Text] [Related]
17. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
[TBL] [Abstract][Full Text] [Related]
18. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
[TBL] [Abstract][Full Text] [Related]
19. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices.
Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ
Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717
[TBL] [Abstract][Full Text] [Related]
20. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]